These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 26137787)

  • 41. Emergence of a small colony variant of vancomycin-intermediate Staphylococcus aureus in a patient with septic arthritis during long-term treatment with daptomycin.
    Lin YT; Tsai JC; Yamamoto T; Chen HJ; Hung WC; Hsueh PR; Teng LJ
    J Antimicrob Chemother; 2016 Jul; 71(7):1807-14. PubMed ID: 26968883
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clonal spread of Staphylococcus aureus heterogeneously resistant to vancomycin in a university hospital in Korea.
    Kim MN; Hwang SH; Pyo YJ; Mun HM; Pai CH
    J Clin Microbiol; 2002 Apr; 40(4):1376-80. PubMed ID: 11923359
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Contribution of selected gene mutations to resistance in clinical isolates of vancomycin-intermediate Staphylococcus aureus.
    Hafer C; Lin Y; Kornblum J; Lowy FD; Uhlemann AC
    Antimicrob Agents Chemother; 2012 Nov; 56(11):5845-51. PubMed ID: 22948864
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The incidence and risk factors for heterogeneous vancomycin intermediate Staphylococcus aureus].
    Feng NN; Wang Q; Song YL; He LX; Zhou CM; Xie HM; Li HY
    Zhonghua Nei Ke Za Zhi; 2013 Apr; 52(4):318-22. PubMed ID: 23925360
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Daptomycin non-susceptibility in vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous-VISA (hVISA): implications for therapy after vancomycin treatment failure.
    Kelley PG; Gao W; Ward PB; Howden BP
    J Antimicrob Chemother; 2011 May; 66(5):1057-60. PubMed ID: 21393156
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Methicillin-resistant Staphylococcus aureus in North-east Croatia.
    Pastuović T; Perić M; Bošnjak Z; Ružman N; Majić PR; Talapko J; Atalić V; Loci-Zvocak S; Vuković D
    Acta Med Acad; 2015; 44(1):10-7. PubMed ID: 26062693
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antibiotic susceptibility pattern of nosocomial isolates of staphylococcus aureus in a tertiary care hospital, Nepal.
    Shrestha B; Pokhrel BM; Mohapatra TM
    JNMA J Nepal Med Assoc; 2009; 48(175):234-8. PubMed ID: 20795464
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Emergence of vancomycin-intermediate Staphylococcus aureus from predominant methicillin-resistant S. aureus clones in a Korean hospital.
    Cha HY; Kim HO; Jin JS; Lee JC
    J Microbiol; 2010 Aug; 48(4):533-5. PubMed ID: 20799097
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Nosocomial infection caused by multidrug-resistant Staphylococcus aureus with reduced susceptibility to vancomycin and teicoplanin.--Yamagata Prefecture, Japan; May 2004-Jun 2005].
    Murata T; Otani K
    Kansenshogaku Zasshi; 2007 Mar; 81(2):183-8. PubMed ID: 17447477
    [TBL] [Abstract][Full Text] [Related]  

  • 50. New epidemiology of Staphylococcus aureus infection in Asia.
    Chen CJ; Huang YC
    Clin Microbiol Infect; 2014 Jul; 20(7):605-23. PubMed ID: 24888414
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Increasing resistance to vancomycin and other glycopeptides in Staphylococcus aureus.
    Tenover FC; Biddle JW; Lancaster MV
    Emerg Infect Dis; 2001; 7(2):327-32. PubMed ID: 11294734
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Guidelines for the control and prevention of meticillin-resistant Staphylococcus aureus (MRSA) in healthcare facilities.
    Coia JE; Duckworth GJ; Edwards DI; Farrington M; Fry C; Humphreys H; Mallaghan C; Tucker DR; ; ;
    J Hosp Infect; 2006 May; 63 Suppl 1():S1-44. PubMed ID: 16581155
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Multiple pathways of cross-resistance to glycopeptides and daptomycin in persistent MRSA bacteraemia.
    Chen CJ; Huang YC; Chiu CH
    J Antimicrob Chemother; 2015 Nov; 70(11):2965-72. PubMed ID: 26216581
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The emergence of vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus.
    Appelbaum PC
    Clin Microbiol Infect; 2006 Mar; 12 Suppl 1():16-23. PubMed ID: 16445720
    [TBL] [Abstract][Full Text] [Related]  

  • 55. High vancomycin minimum inhibitory concentrations with heteroresistant vancomycin-intermediate Staphylococcus aureus in meticillin-resistant S. aureus bacteraemia patients.
    Wang JL; Lai CH; Lin HH; Chen WF; Shih YC; Hung CH
    Int J Antimicrob Agents; 2013 Nov; 42(5):390-4. PubMed ID: 24041465
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci, and other Gram-positives in healthcare.
    Calfee DP
    Curr Opin Infect Dis; 2012 Aug; 25(4):385-94. PubMed ID: 22614523
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of the effectiveness of common hospital hand disinfectants against methicillin-resistant Staphylococcus aureus, glycopeptide-intermediate S. aureus, and heterogeneous glycopeptide-intermediate S. aureus.
    Wootton M; Walsh TR; Davies EM; Howe RA
    Infect Control Hosp Epidemiol; 2009 Mar; 30(3):226-32. PubMed ID: 19199533
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Does resistance in severe infections caused by methicillin-resistant Staphylococcus aureus give you the 'creeps'?
    Brink AJ
    Curr Opin Crit Care; 2012 Oct; 18(5):451-9. PubMed ID: 22941206
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Phenotypic characteristics and comparative proteomics of Staphylococcus aureus strains with different vancomycin-resistance levels.
    Sirichoat A; Lulitanond A; Kanlaya R; Tavichakorntrakool R; Chanawong A; Wongthong S; Thongboonkerd V
    Diagn Microbiol Infect Dis; 2016 Dec; 86(4):340-344. PubMed ID: 27717648
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Australian Staphylococcus aureus Sepsis Outcome Programme annual report, 2013.
    Coombs GW; Nimmo GR; Daly DA; Le TT; Pearson JC; Tan HL; Robinson JO; Collignon PJ; McLaws ML; Turnidge JD;
    Commun Dis Intell Q Rep; 2014 Dec; 38(4):E309-19. PubMed ID: 25631593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.